Read your latest personalised notifications
No account yet? Start here
Don't miss out
Ok, got it
The HFA was proud to launch its third edition of the Career Cafe at Heart Failure 2018 in Vienna!
In a relaxed atmosphere, with a cup of coffee or tea, young heart failure enthusiasts have been given the opportunity to meet internationally renowned experts in the field.
The third edition of the HFA Career Cafe at Heart Failure 2018 was a great success, many thanks to the Mentors and everyone who applied!
We look forward to renewing this event at Heart failure 2019.
The HFA Career Cafe is the meeting place for the future generation of heart failure specialists to interact with the great leaders of their specialty.
During individual interviews of 12 minutes, the selected applicants had the privilege to seek career development advice and recommendations from renowned professionals with years of successful careers behind them.
This is a unique platform where long-lasting generational relationships are possible!
Applications are done online and are free. Applicants are asked to select the mentors they wish to meet in order of preference.
All applicants have to be:
In total, 20 applicants will be selected based on their motivations and CV. Each applicant will be assigned up to 3 interviews.
Priority will be given to HFA Gold & Silver Members.
ATTENTION: Applicants must be sure to not have any conflicting role at the same time (Moderated Poster, etc).
2019 Mentors list will be avalaible in March 2019
Area of expertise: acute and chronic heart failure, left ventricular healing and remodelling, peripartum cardiomyopathy, translational studies.
Professor Bauersachs studied Medicine at the University of Freiburg. After training as Clinical and Research Fellow at the Universities of Frankfurt and Heidelberg/Mannheim, in 1999 he moved to the University Hospital Wuerzburg where he became Consultant and Lecturer in Internal Medicine and Cardiology and was Associate Professor in the Department of Medicine from 2008 to 2010. Since 2010 he is Full Professor and Director of the Department of Cardiology and Angiology at Hannover Medical School.
Professor Bauersachs is an interventional cardiologist with special interests in acute coronary syndromes, left ventricular healing and remodelling, acute and chronic heart failure, as well as intensive care. He is particularly interested in the pathophysiology and treatment of peripartum cardiomyopathy, in aldosterone and mineralocorticoid receptor-mediated mechanisms, and the role of non-coding RNAs. He is Study Chair of the DIGIT-HF study investigating the effect of Digitoxin on morbidity/mortality in patients with advanced heart failure.
Professor Bauersachs is Fellow and Board Member of the Heart Failure Association (HFA) of the ESC, Chair of the HFA Study Group on Peripartum Cardiomyopathy, and Past Chair of the Working Group on Myocardial Function. He is Chair of the Cardiovascular Section of the Fachkollegium Medizin, Deutsche Forschungsgemeinschaft (DFG), Member of the Steering Committee of the DFG-funded Cluster of Excellence REBIRTH, and Speaker of the Clinical Research Group (KFO) 311 “(Pre-)terminal heart and lung failure - mechanical unloading and repair” funded by the DFG.
Area of expertise: Myocardial and ventricular function (contraction, relaxation and filling, non-uniformity) in health and disease, in particular in heart failure, including the role of cardiac endothelium in endothelial-cardiomyocyte cell communication.
Dirk L Brutsaert is a Professor-Emeritus in the Departments of Medicine, Cardiology and Pharmacology at the University of Antwerp. Between 1966 and 2002 he served as a Professor of Physiology and Medicine in the Department of Medicine at the University of Antwerp; from 1981 to 2002 he was Co-Chairman of the Department of Cardiology at University Hospital Antwerp; and he was an Honorary Consultant in the Department of Cardiology at AZ Middelheim Hospital, University of Antwerp (2002-2006).
Professor Brutsaert is Past President of the Heart Failure Association of the European Society of Cardiology (ESC) and of the Royal Academy of Medicine of Belgium (both 2004–2006).
Barbara Casadei is a British Heart Foundation (BHF) Professor of Cardiovascular Medicine at the University of Oxford, Deputy Head of the Division of Cardiovascular Medicine, Honorary Consultant Cardiologist at the Oxford University Hospitals NHS Trust and Fellow of Wolfson College. She is the Lead of the Myocardial Theme of the Oxford BHF Centre of Excellence and the Lead of the Cardiovascular Theme of the Oxford NIHR Biomedical Research Centre.
Professor Casadei graduated in Medicine (cum Laude & Gold Medal) at the University of Pavia, Italy and moved to Oxford in 1989 to undertake her clinical and research training. She was awarded the Joan and Richard Doll Fellowship at Green College in 1991, a DPhil in Cardiovascular Medicine in 1995, and a BHF Senior Research Fellowship in 2001. Professor Casadei is a Fellow of the UK Academy of Medical Sciences and the President-Elect of the European Society of Cardiology (ESC). She has delivered several keynote lectures including The Joan Mott Prize Lecture of the Physiological Society (2004); The William Harvey Lecture on Basic Science and Silver Medal of the ESC (2013); The Thomas Lewis Lecture and Silver Medal of the British Cardiovascular Society (2014); The Carmeliet-Coraboeuf-Weidmann Lecture (2015); The Frontiers in Cardiovascular Biology Keynote Lecture (2016); The Inaugural Lecture of the International Society of Hypertension Women in Hypertension Research Network (2016); The Brutsaert Lecture of the Heart Failure Association; The William H Gaasch lecture, University of Massachusetts, USA and The Inaugural Sandra Bruni Mattei Lecture, University of Pavia (2017).
Professor Casadei provides a clinical service at the Oxford University Hospitals NHS Trust’s John Radcliffe Hospital and leads a bench-to-bedside translational research programme, which spans from clinical trials to bench-based investigation in human tissue and cells.
Wijesurendra RS, Liu A, Eichhorn C, Ariga R, Levelt E, Clarke WT, Rodgers CT, Karamitsos TD, Bashir Y, Ginks M, Rajappan K, Betts T, Ferreira VM, Neubauer S, Casadei B.
Lone Atrial Fibrillation Is Associated With Impaired Left Ventricular Energetics That Persists Despite Successful Catheter Ablation. Circulation. 2016 Oct 11;134(15):1068-1081. Published with an EditorialKirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B, Castella M, Diener HC, Heidbuchel H, Hendriks J, Hindricks G, Manolis AS, Oldgren J, Popescu BA, Schotten U, Van Putte B, Vardas P.
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS: The Task Force for the management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Endorsed by the European Stroke Organisation (ESO). Eur Heart J. 2016 Aug 27. pii: ehw210. [Epub ahead of print] PubMed PMID: 27567408.
Zheng Z, Jayaram R, Jiang L, Emberson J, Zhao Y, Li Q, Guarguagli S, Hill M, Chen ZM, Collins R, Casadei B.
Perioperative rosuvastatin in cardiac surgery New Engl Med J 2016;374(18):1744-53Reilly SN, Liu X, Carnicer R, Recalde A, Muszkiewicz A, Jayaram R, Carena MC, Stefanini M, Surdo NC, Wijesurenda R, Lomas O, Ratnatunga C, Sayeed R, Krasopoulos G, Rajakumar T, Bueno-Orovio A, Verheule S, Fulga TA, Rodriguez B, Schotten U, Casadei B. Atrial-specific upregulation of miR-31 in human atrial fibrillation begets the arrhythmia by depleting dystrophin and neuronal nitric oxide synthase. Science Transl Med 2016 Vol. 8, Issue 340: 340ra74
Carnicer R, Hale AB, Suffredini S, Liu X, Reilly S, Zhang MH, Surdo NC, Bendall JK, Crabtree MJ, Lim GB, Alp NJ, Channon KM, Casadei B. Cardiomyocyte GTP Cyclohydrolase 1 and Tetrahydrobiopterin Increase NOS1 Activity and Accelerate Myocardial Relaxation. Circ Res. 2012 Aug 31;111(6):718-27.
Area expertise: exercise physiology, the possible role of oxygen therapy for heart failure and the natural history of heart failure.
Professor Andrew Clark is professor of clinical cardiology in the University of Hull. He was educated at Pembroke College, Cambridge, and trained in medicine at Westminster Medical School. He trained in heart failure at the National Heart and Lung Institute and Glasgow Western Infirmary. He has published widely on aspects of heart failure, and is co-editor of the Oxford Textbook of Heart Failure. He is the past Chair of the British Society for Heart Failure.
University of Bergen, Stavanger University Hospital, Stavanger, Norway.
Kenneth Dickstein was born in Philadelphia and completed undergraduate education at the Univ. of Pennsylvania. He has medical degrees from the Univ. of London and the Royal College of Surgeons. He was a research fellow at Harvard Medical School (1988-90) and completed his PhD in exercise physiology at the Univ. of Bergen in 1992. Professor Dickstein was in charge of the coronary care unit at Stavanger University Hospital, full professor of medicine at the Univ. of Bergen and was coordinator for the medical student teaching program at the hospital. His primary focus is clinical research in heart failure. For the years 2014-2016 he has been included in the Reuters list of the top 1% of the most influential researchers internationally. Professor Dickstein is Past-President of the Heart Failure Association of the European Society of Cardiology and a councillor on the ESC Board. He was Chairman of the Task Forces for two of the ESC Guidelines on Heart Failure. In 2016, he received the Research Prize from the Norwegian National Society and the Falch Research Prize from the University of Bergen in 2017. He is the founder of the ESC website heartfailurematters.org and is an active member of numerous editorial boards and steering committees and an associate editor of the European Journal of Heart Failure and Circulation. Prof. Dickstein has published over 360 scientific papers and held over 300 invited lectures at international venues. He resides with his wife and 2 sons on the west coast of Norway and spends his summers fly fishing.
Stavanger University Hospital, Cardiology Division (Stavanger, NO)
Director of University of Gothenburg Centre for Person-Centred Care (GPCC), in Sweden.
In 2007, Inger Ekman was appointed full professor in Care Science at Sahlgrenska Academy, University of Gothenburg.
During the period 2006-2010, Inger Ekman was head of Institute of Health and Care Sciences, and 2010-2012 vice dean at the medical faculty (Sahlgrenska academy). Inger Ekman's research focuses on communication and symptoms in patients with long term illness, particularly chronic heart failure and evaluation of person-centred care interventions.
Inger Ekman has more than 140 publications in scientific journals and is at present the director of GPCC. Research on person-centred care is the focus of GPCC which is built on a large governmental grant (15 million Euro) involving about 30 multidisciplinary research groups for example care sciences, medicine, pedagogics and economics. Ekman is also since 2016 the coordinator of COST 15222, a European initiative on testing implementation of person-centred care and health promotion within the frame of cost containment with maintained or improved quality of care in five countries in Europe.
Dean, School of Medicine
University of Cyprus
Professor of Cardiology, University of Cyprus &
National and Kapodistrian University of Athens
Gerasimos Filippatos studied Medicine at the University of Patras, GR, and earned his doctorate Cum Laude from the University of Athens. He subsequently completed his clinical training in Chicago, USA; and Cambridge, UK.
Prof Filippatos is past President of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC). He has served as Chair of the Clinical Section and the Committee on Acute Heart Failure of the HFA, and as Chair of the ESC’s Working Group on Acute Cardiac Care. He was also Coordinator of the ESC Congress Programme Committee for Heart Failure and Acute Cardiac Care, member of the ESC Practice Guidelines Committee and American College of Cardiology/American Heart Association HF Guidelines Writing Committee, and International Governor of the American College of Chest Physicians.
Dr. Filippatos is Associate Editor of the European Heart Journal (impact factor>20), the International Journal of Cardiology and of the Journal of Cardiovascular Medicine. He has published over 450 articles in peer-reviewed journals and authored more than 30 book chapters including the “Acute Heart Failure” chapter in Braunwald’s and Oxford Desc Reference: Cardiology. Moreover, he has (co) edited 5 books including the ESC Textbook of Acute and Intensive Cardiac Care, Highly Commended in the 2011 British Medical Association Medical Book Awards; in 2014 presented the book Heart Failure: The Expert’s Approach and in 2016 the pocket book: Treatment Algorithms in Heart Failure.
Prof. Filippatos is in the Thomson Reuters list of Highly Cited Researchers.
Honorary Member of many Cardiac Societies: ie French Cardiac Society, Romanian Cardiac Society, Hungarian Cardiac Society.
Arno W. Hoes studied medicine at the Radboud University Nijmegen. He obtained his PhD degree at Erasmus University Rotterdam and was trained in Clinical Epidemiology at Erasmus Medical Center Rotterdam and the London School of Hygiene and Tropical Medicine.
In 1998 he was appointed professor of Clinical Epidemiology and General Practice at the Julius Center for Health Sciences and Primary Care of the University Medical Center in Utrecht. Since 2010, he is the Chair of the Julius Center.His clinical research topics include the diagnosis, prognosis and therapeutic interventions in cardiovascular disease, and, in particular, heart failure. Many of his studies in heart failure are conducted in the primary care setting and focus on improving early diagnosis and prognosis of heart failure.
He is involved in many ESC activities and especially the HFA: he is a board member of the HFA and chairs its Patient Care Committee. Professor Hoes has been (co-)applicant of many research grants. He has (co-)authored over 600 papers in peer-reviewed journals (Hirsch index 76) and more than 55 PhD students completed their PhD thesis under his supervision.
Prof. Dr. Tiny Jaarsma (RN NFESC FAHA FAAN) is a professor in caring sciences/nursing science at the Faculty of Medicine and Health Sciences of the University of Linköping, Sweden. Her research focuses on the consequences of heart failure for patients and their families and developing and testing interventions to enhance their self-care. Her research has been published in over 320 publications ranging from short practical communications, book chapters to scientific publications in peer reviewed journals.
Tiny Jaarsma was trained as a nurse in Groningen, (NL) and she worked with cardiac patients since 1988, on the cardiology ward and in the Heart Failure clinic. She received her master degree from the University of Maastricht in 1992, as part of a nurse fellowship of the Netherlands Heart Foundation. She studied 6 months at the UCLA in 1993 with prof Dracup and completed her doctoral degree in 1999, with a thesis entitled “heart failure: nurses’ care”.
Currently she is the principle investigator of the ‘HF-WII’ study, an RCT on the effect of exergaming to increase physical activity in patients with heart failure. Her other research is aimed at improving communication between health care providers and patients regarding end of life issues (TALK-HF) Together with prof Anna Strömberg she is currently leading a research team with junior and senior researchers, international postdoc. She is the editor-in chief of the European Journal of Cardiovascular Nursing and the chair of the Science Committee of the ESC Council of Cardiovascular Nursing and Allied Professionals, involved in the Nursing Council of the AHA and is a former board member of the Heart Failure Association of the ESC. Professional activities include membership of national and international committees and guidelines (ESC, AHA), reviewer and member of editorial boards of peer-reviewed journals.
Dipak is a Clinician Scientist in Cardiovascular Medicine at the University of Birmingham, a Consultant Cardiologist specialising in cardiac imaging, and holds a prestigious National Institute for Health Research (NIHR) Fellowship. Dipak works with the European Society of Cardiology (ESC) on the Education Committee, and helped to write the 2016 ESC Guidelines for the Management of Atrial Fibrillation. His research focuses on the interaction of heart failure and atrial fibrillation, published in leading journals such as the Lancet, BMJ, Journal of the American College of Cardiology and the European Heart Journal. He supervises a number of PhD students including basic, translational and clinical science, leads an international heart failure consortium (the Beta-blockers in Heart Failure Collaborative Group), and is Chief Investigator of the first randomised controlled trial of digoxin in patients with atrial fibrillation and symptoms of heart failure. Dipak also collaborates on major European grants in this field, with an interest in trial methodology, robust statistical evaluation, big data approaches and novel technology such as mobile applications and wearable devices.
Lars H Lund, MD PhD, is an Associate Professor in the Department of Medicine, Karolinska Institutet, and Senior Consultant in the Department of Cardiology, Karolinska University Hospital. He trained in medicine, cardiology and heart failure at Duke University and Columbia University. His expertise is HF big data and registry-based comparative outcomes studies and pragmatic trials. He is active in programs to improve utilization of existing evidence based interventions in heart failure with reduced ejection fraction and advanced heart failure, such as devices and transplantation, as well as in novel interventions and pragmatic trials of new use applications of existing drugs in heart failure with preserved ejection fraction. He has extensive experience and leadership positions in heart failure registries: He is Associate Director of the Swedish Heart Failure Registry (SwedeHF) Research Program; a board member of the Heart Failure Association (HFA) and a member of the working group for the HFA European Heart Failure Registry of the ESC Observational Research Program (EORP); chairman of the Executive Committee of the ESC HF Long-Term Regsitry, Associate Director the International Society for Heart & Lung Transplantation (ISHLT) Registry, and on the Steering Committee of the ISHLT International Registry for Mechanical Circulatory Support (IMACS). He is on steering committees for several trials and observational studies. He is or has been Associate Editor for and on the Editorial Boards of numerous journals including Circulation, European Journal of Heart Failure and Journal of Cardiac Failure. He has over 200 publications in peer reviewed journals, an H-index of 30, and one patent.
Area of expertise: Heart failure, Cardio-Oncology and Takotsubo syndrome
Alexander Lyon is a Senior Lecturer in Cardiology at Imperial College London and a Consultant Cardiologist at the Royal Brompton Hospital. Dr Lyon is a current member of the HFA board and chair of the HFA Cardio-Oncology and Takotsubo Syndrome Study Groups. Dr Lyon is president of the British Cardio-Oncology Society which hosted the Global Cardio-Oncology Summit in London in September 2017. Dr Lyon studied Medicine at Oxford University and he completed his PhD in gene therapy for heart failure at Imperial College London, and postdoctoral research at Mount Sinai Hospital in New York.
Area of expertise: pathophysiology and medical treatment of heart failure.
Christoph Maack is a Heisenberg Professor for Cardiovascular Physiology and Bioenergetics and a Senior Physician at the Department of Cardiology at the University of the Saarland in Homburg, Germany. His research focusses on the pathophysiology and treatment of heart failure, with a special focus on metabolic aspects and myocardial function. For his research, Professor Maack was awarded the Albert-Fraenkel- (2014) and the Arthur-Weber Awards (2015) of the German Cardiac Society, respectively. He was a Board member of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC) from 2010-2016. From 2011-2014 he was the Coordinator of the Translational Research Committee of the HFA, and from 2014-2016 served on the Executive Committee of the HFA Board as the Chair of the Basic Science section. From 2013-2016, he organized the HFA Winter Meeting on Basic and Translational Research in Les Diablerets, Switzerland. Since 2015 he serves on the Programm Committee of the German Cardiac Society.
Prof. McDonagh completed her general medical training in Edinburgh. She was then a Research Fellow in Cardiology at the Western Infirmary in Glasgow from 1991-1994 and a Lecturer at the CRI in Heart Failure, University of Glasgow (Honorary Senior Registrar) from 1994-1999. Working on the epidemiology of Left Ventricular Dysfunction and Natriuretic Peptides with Professor Henry J Dargie.Subsequently she was appointed as a Senior Lecturer (Honorary Consultant Cardiologist) at the University of Glasgow and Glasgow Royal Infirmary where she ran the Heart Failure Service and was the Cardiologist involved in the Heart Transplant Programme (1999-2004). She was appointed as a Consultant Cardiologist with an Interest in Heart Failure at the Royal Brompton Hospital, London (2004-2011) before moving to King's College Hospital as a Consultant Cardiologist and Professor of Heart Failure.
Her research interests are in clinical heart failure in particular the epidemiology of heart failure and left ventricular dysfunction and the role of biomarkers.
Marco Metra is Professor of Cardiology and Director of the Institute of Cardiology of the Department of Medical and Surgical Specialties, Radiological Sciences and Public Health of the University and Civil Hospitals of Brescia, Italy.
He is Editor-in-Chief of the European Journal of Heart Failure, the official journal of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC), Senior Consulting Editor of the European Heart Journal and member of the Editorial board of many other scientific journals. His research activity is focused on treatment of heart failure and its comorbidities. He has had a leading role in multiple trials of new therapies in patients with heart failure.
He is the ex-officio member of the board of HFA, a fellow of HFA, ESC, the Heart Failure Society of America, a member of the Italian Society of Cardiology (SIC) and many other scientific societies.
He is author of more than 500 articles in peer-reviewed journals with a current google scholar H index of 76.
Prof Jillian Riley is a lecturer at the National Heart and Lung Institute, Imperial College. Currently she is developing a new MSc in Cardiovascular and Respiratory Healthcare which will start in October 2018.
With a particular interest in supporting the delivery of cardiac care Dr Riley was involved in the development of the UK National Service Framework for Coronary Heart Disease. Subsequently she was instrumental in the development of the British Association for Nursing in Cardiac Care (BANCC), an affiliated group to the British Cardiovascular Society, and was President of BANCC until 2003. Jill has served on a number of expert committees both nationally and internationally. Currently she sits on the Executive committee of the board of the European Heart Failure Association of the ESC. Dr Riley also reviews the evidence on the organisation of care and monitoring for the NHS evidence update on Heart Failure and sits on the cardiovascular strategic leadership group for NHS London where she co-chairs the heart failure subgroup.
Dr Riley has co-authored a text on cardiothoracic nursing and contributed to a number of other text books and publications. She is an associate editor for the European Journal of Heart Failure and sits on the editorial board of the European Journal of Cardiovascular Nursing and on the British Journal of Cardiac Nursing.
Consultant Cardiologist and Professor of CardiologySt George’s Hospitals NHS Trust University of London
After obtaining his MD in Medicine and Surgery at the La Sapienza University of Rome with full honors in 1988, Giuseppe Rosano obtained his specialization in Cardiology in 1992, before attaining his MSc and his PhD in Medical Sciences from the Imperial College in London.
Professor Rosano’s areas of scientific interest include experimental and clinical pharmacology, heart failure, modulation of cardiac and muscular metabolism in heart failure, diabetes and heart failure. He has authored over 400 peer-reviewed articles, 5 books and 28 book chapters.
He is currently Consultant Cardiologist and Professor of Cardiology at the St George’s University Medical School in London and Professor of Pharmacology at the University of Catanzaro, Italy.
He currently serves as an expert in the area of Cardiovascular Medicine for the European Assessment Office of the Italian Drug Agency (AIFA), he is core member of the Cardiovascular Working Party of the European Medicines Agency.He is, board member of the Heart Failure Association (HFA), Chairman of the Education committee of the HFA and Chairman of the Study Group on Diabetes and Hypertension of the HFA.
Area of expertise: cardiovascular disease in pregnancy and postpartum is one of her main areas of clinical and pathophysiological research.
Prof. Karen Sliwa, MD, PhD, FESC, FACC, DTM & H- is the Director of the Hatter Institute for Cardiovascular Research in Africa (www.hatter.uct.ac.za), University of Cape Town, South Africa.Born in Germany, studying Medicine, undergoing training as a physician and cardiologist in a number of countries, she lives in South Africa since 1992.
Clinically her interests are in heart failure, rheumatic heart disease and all aspects of cardiovascular disease in pregnancy and postpartum. Her research spans from basic science to clinical studies to population studies. She has designed a number of innovative research programs and leveraged funding for several major research projects, not only in South Africa and the rest of Africa, but also internationally. She has published more than 200 articles and her work is highly cited.
In recognition of her work Prof Sliwa has received several prestigious awards.
Karen Sliwa serves on a number of editorial boards and is also an editorial consultant to ‘The Lancet’. Furthermore, she is the past president of the South African Heart Association, serves on the board of the South African Heart Failure Society (Hefssa; www.hefssa.org), which was established under her leadership 2005. She also president elect World Heart Federation ( 2017-2019),a member of the European Cardiac Society International Affairs committee and is board member of the Pan African Society of Cardiology.
Karl Swedberg is Senior Professor of Medicine, Sahlgrenska Academy, University of Gothenburg, Sweden and Professor of Cardiology, National Heart and Lung Institute, Imperial College, London. His research interests include beta-blockers and angiotensin-converting enzyme inhibitors (ACEIs) and their effects on heart failure (HF) and myocardial infarction (MI), neuroendocrine activation in HF and the treatment of chronic HF. Professor Swedberg was the first to report on the survival benefits of a beta-blocker (1979), ACEI (1987) and angiotensin receptor blocker (2003) in chronic HF. He has published widely, including over 320 original research papers and 25 textbook chapters. Professor Swedberg was included in the 2016 listing of Highly Cited Researchers by Thomson-Reuters. In addition, he has been a steering committee member for numerous outcome trials in HF and MI and is a member of the Executive Committee for the PARADIGM-HF trial.
Professor Swedberg received the 2004 Kaufman Award from Cleveland Clinics (USA) for his HF research, the European Society of Cardiology Gold Medal 2007 for his outstanding contributions to the cardiovascular field and in 2016 the Lifetime Achievement Award from HFA. He has been an Honorary Member of the Thai Heart Association since 2007, the Swedish Society of Cardiology since 2008, and the Japan Circulatory Society since 2009. In addition, Professor Swedberg was Editor-in-Chief of European Journal of Heart Failure from 2005 to 2009. He is associate Editor of the European Heart Journal since 2012.
Faiez Zannad, MD, PhD, FESC is Professor of Therapeutics at the University of Lorraine in Nancy, France. Cardiologist and heart failure specialist, PhD in clinical pharmacology (Oxford, UK). Head of the Division of Heart Failure and Hypertension and Director of the Inserm Clinical Investigation Center at “Institut Lorrain du Coeur et des Vaisseaux”, Nancy. Professor Zannad leads two EU FP7 granted programs: HOMAGE (omics biomarkers for mechanistic phenotyping and prediction of drug response [www.homage-hf.eu]) and FIBROTARGETS (fibrosis as a biotarget [www.fibrotargets.eu]). As the primary investigator or member of oversight committees in major clinical trials, he pioneers and/or made significant contributions to evidence-based heart failure therapy, mainly mineralocorticoid receptor antagonists (RALES, EPHESUS, EMPHASIS-HF), and beta-blockers (CIBIS) as well as in major comorbid diseases such as sleep disordered breathing (SERVE-HF), autonomic nervous dysfunction (NECTAR-HF, BEAT-HF), and diabetes (EXAMINE, EMPEROR), chronic kidney disease (FOSIDIAL, AURORA, ALCHEMIST), in diabetes (EXAMINE, EMPEROR), thrombosis in heart failure (COMMANDER-HF). He served as Chairman of the French Society of Hypertension, Chairman of the ESC Working Group on pharmacology and drug therapy, and board member of the ESC Heart Failure Association. He is the founder and is currently organizing the Global CardioVascular Clinical Trialists (CVCT) Forum and Workshop, an annual international think tank gathring dedicated to the science of clinical trials, with meetings in Paris, Washignton DC, Middle East and Asia.
Dr Zannad will be presented with an HFA Lifetime Achievement Award at this year's Heart Failure congress in Paris, and he will give the Philip Poole Wilson lecture during the Inaugural Session on: Mineralocorticoid receptor antagonists. Navigating the landscape, from trials to clinical practice and to reverse translational science Into Dr Zannad obtained 2017 HFA Lifetime Achievement Award.
"Meeting the experts at HF Career Cafe was an extraordinary opportunity to show my work during my Master and to get advice about the most important ways to develop my ideas, in order to proceed to a doctoral level."
"Heart Failure Career Cafe is the chance to connect with legends and share with them the results of your work. It was great to discuss directly with them and receive not common and usual advices but the personal ones.Moreover, seniors shared with me e-mails and other useful contacts and links. The whole Career Café experience was unforgettable and absolutely practical! It turned my career on the next level …"
"It was a great experience for me! I had an opportunity to communicate with 3 professors (Theresa McDonagh, Tiny Jaarsma and Jillian Riley), who are among the best specialists in the field of cardiology. Professors told me about future opportunities of my work, they suggested different training courses in heart failure and gave me many good advise.
Thanks to this great Career Cafe and professors I wrote 4 articles and gave an application to have a training course in Heart Failure. Also, with the help of professors advises, I created a mobile app for patients with Heart Failure. I am going to defend my dissertation in May 2018 and become a PhD."
"The Career Cafe allowed me to meet with experts in their field who shared great advice on career development, particularly long term planning. I found it encouraging and it led me to make beneficial decisions about my own career. In addition I got introduced to the heart Failure Specialists of Tomorrow group (HoT)."
"The Career Cafe is the ideal forum to talk with key opinion leaders.
The Career Cafe allowed me to put my research interest in the spotlight. The mentor gave important methodologic advise on ongoing research and invited me to submit my research to their journal. "
"The Career Cafe gave me the opportunity to meet high-esteemed experts with important careers in the field of heart failure, who provided me with significant perspective on the steps I should follow to achieve my goals in the scientific and academic environment.
Following the acquaintances I made at the Career Cafe, I had a chance to visit for 2 weeks a renowned research center of Europe. Moreover, I was given the opportunity to perform high-quality research and write relative manuscripts, which I hope to publish shortly."
"This experience is a way to push yourself to continue working hardly in order to get the professional or researcher you want to be."
"For me Career Cafe means impressive conversation, valuable advices, getting new contacts which contributed to my professional development. All of this gave me the possibility to begin a new scientific project.
Firstly, we have created the collaboration between one of the mentors and my Bukovinian State Medical University. "
"During Heart Failure Career Cafe I had the chance to interact with renowned professionals with years of experience in my field of interest. I had my questions answered and I was given advice and guidance for my future development. During each 12 minute talk, all three of my mentors, gave me equipment to organize my future steps, guided me to take efficient decisions, and offered me excellent professional opportunities. Heart Failure Career Cafe was like a scientific market place where you could definitely purchase professional guidance, mentorship, research and job opportunities.
One of the professors offered me the option to work in a research institute in the field of my interest."
"It was a great experience to discuss my career issues with opinion leaders in heart failure. I received several quite practical recommendations. One of them was to participate in postgraduate heart failure course. Although my previous application was not accepted i took another chance and was lucky. Now I'm happy and proud to be part of this course."
"Through the Career Cafe program, I talked face-to-face with the HF masters and it really widened my view of the HF field so that I discovered new important research themes. Also, one of the articles which started before the congress was published recently with the co-authorship of the Career Cafe mentor and I’m preparing a new manuscript with the co-authorship of another mentor whom I first met in the 2017 Career Cafe."
Our mission: To reduce the burden of cardiovascular disease
© 2018 European Society of Cardiology. All rights reserved